Long-term safety of continuous levodopa/carbidopa infusion with ND0612: Data from patients who continued past one year in the BeyoND study
Objective: To report long-term safety and tolerability data from the ongoing BeyoND study (NCT02726386) for patients who continued treatment past the one-year primary endpoint. Background:…Comparison of Disease Progression in Patients with Brain-first versus Body-first Parkinson’s Disease
Objective: This study aimed to compare the clinical progression between brain-first and body-first PD groups using cardiac sympathetic denervation (CSD). Background: Brain-first and body-first Parkinson’s…Preferences for discussing sexual health concerns
Objective: To investigate the sexual needs of PwP, and understand their preferences for discussing sexual health concerns.To propose an intervention framework tailored for PwP in…LRRK2 and GBA major variants in the New York Mount Sinai BioMe Biobank
Objective: To characterize the frequency of major LRRK2 and GBA variants in a multi-ethnic New York cohort with and without Parkinson disease (PD). Background: There…Quality of Life and Motor Outcomes for Parkinson’s Disease Patients 12 Months After Deep Brain Stimulation in China
Objective: Demonstrate improvement in Parkinson’s disease (PD)-related quality of life (QoL) for Deep Brain Stimulation (DBS) patients in a prospective, multicenter study conducted in China.…History of Comorbidities and their Association with Developing Cognitive Dysfunction in PD
Objective: To examine comorbidities associated with incident cognitive dysfunction in PD. Background: The risk of dementia is up to six-times higher in PD compared to…A Week in the Life with Parkinson’s Disease: A Holistic Overview from Four Digital Technologies
Objective: To showcase a day in the life of a person with Parkinson’s disease (PD) using four multimodal digital technologies. Background: Assessments of PD are…Systematic Literature Review of Key Outcomes Used to Assess Adjunctive Treatments for Parkinson’s Disease
Objective: Understand key efficacy outcomes used to assess adjunctive treatments to carbidopa/levodopa (CD/LD) for Parkinson’s disease (PD). Background: CD/LD is widely considered the most effective…Trends in incidence of hospitalizations in Parkinson´s Disease in Spain (2010-2019)
Objective: To estimate the incidence of in-hospital admissions of Parkinson´s disease (PD) in Spain during the last decade (2010-2019) and describe the epidemiology of these…Botulinum Toxin Therapy for Medication and DBS Refractory Foot Dystonia of Parkinsonism
Objective: To determine efficacy and safety of BTX therapy in patients with medically refractory foot dystonia secondary to Parkinson’s disease (PD) or atypical Parkinsonism (AP)…
- « Previous Page
- 1
- …
- 296
- 297
- 298
- 299
- 300
- …
- 436
- Next Page »